i already read your post and liked it.also read an
Post# of 148168
"I would suppose that any buyout at these prices 15-30 would include CVRs (contingent value rights) as other indications are validated and FDA approved. So while the actual buyout share price would be “low” the future pipeline value could be worth for example $10 per indication. This would drive the total value much higher. Just my opinion."